FI885943A - A process for the preparation of new therapeutically useful adenosine derivatives and intermediates - Google Patents

A process for the preparation of new therapeutically useful adenosine derivatives and intermediates Download PDF

Info

Publication number
FI885943A
FI885943A FI885943A FI885943A FI885943A FI 885943 A FI885943 A FI 885943A FI 885943 A FI885943 A FI 885943A FI 885943 A FI885943 A FI 885943A FI 885943 A FI885943 A FI 885943A
Authority
FI
Finland
Prior art keywords
intermediates
preparation
therapeutically useful
adenosine derivatives
new therapeutically
Prior art date
Application number
FI885943A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI90429B (en
FI90429C (en
Inventor
Brian Evans
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of FI885943A publication Critical patent/FI885943A/en
Publication of FI90429B publication Critical patent/FI90429B/en
Application granted granted Critical
Publication of FI90429C publication Critical patent/FI90429C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI885943A 1987-12-23 1988-12-22 A process for the preparation of new therapeutically useful adenosine derivatives and intermediates FI90429C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB878729994A GB8729994D0 (en) 1987-12-23 1987-12-23 Chemical compounds
GB8729994 1987-12-23

Publications (3)

Publication Number Publication Date
FI885943A true FI885943A (en) 1989-06-24
FI90429B FI90429B (en) 1993-10-29
FI90429C FI90429C (en) 1994-02-10

Family

ID=10628947

Family Applications (1)

Application Number Title Priority Date Filing Date
FI885943A FI90429C (en) 1987-12-23 1988-12-22 A process for the preparation of new therapeutically useful adenosine derivatives and intermediates

Country Status (36)

Country Link
US (1) US5032583A (en)
EP (1) EP0322242B1 (en)
JP (1) JP2736088B2 (en)
KR (1) KR890009967A (en)
CN (1) CN1024198C (en)
AT (1) ATA315488A (en)
AU (2) AU612747B2 (en)
BE (1) BE1002167A5 (en)
CA (1) CA1320195C (en)
CH (1) CH677495A5 (en)
CZ (1) CZ403991A3 (en)
DE (2) DE3856154T2 (en)
DK (1) DK170894B1 (en)
ES (1) ES2012927A6 (en)
FI (1) FI90429C (en)
FR (1) FR2629715B1 (en)
GB (2) GB8729994D0 (en)
GR (1) GR1000307B (en)
HK (1) HK1009650A1 (en)
HU (1) HU203364B (en)
IE (1) IE61302B1 (en)
IL (1) IL88765A (en)
IT (1) IT1224840B (en)
LU (1) LU87414A1 (en)
MX (1) MX14331A (en)
NL (1) NL8803140A (en)
NO (1) NO171506C (en)
NZ (1) NZ227485A (en)
PH (1) PH25932A (en)
PL (1) PL158800B1 (en)
PT (1) PT89328B (en)
RU (2) RU1826971C (en)
SE (1) SE8804609L (en)
SG (1) SG44701A1 (en)
YU (1) YU234188A (en)
ZA (1) ZA889593B (en)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2226027B (en) * 1988-12-13 1992-05-20 Sandoz Ltd Adenosine derivatives,their production and use
FR2665362B1 (en) * 1990-08-03 1994-12-09 Cepbepe SUBSTANCE CONTAINING, AS ACTIVE INGREDIENT, A N6 SUBSTITUTED ADENOSINE AND ITS APPLICATION.
AU654507B2 (en) * 1990-09-25 1994-11-10 Rhone-Poulenc Rorer International (Holdings) Inc. Compounds having antihypertensive and anti-ischemic properties
US5561134A (en) * 1990-09-25 1996-10-01 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
GB9111580D0 (en) * 1991-05-30 1991-07-24 Wellcome Found Nucleoside derivative
DK62692D0 (en) * 1992-05-14 1992-05-14 Novo Nordisk As
US5672588A (en) * 1992-05-20 1997-09-30 Novo Nordisk A/S Purine derivatives
US5443836A (en) * 1993-03-15 1995-08-22 Gensia, Inc. Methods for protecting tissues and organs from ischemic damage
CA2186847A1 (en) * 1994-05-10 1995-11-16 Fulvio Gadient Adenosine derivatives
GB9421133D0 (en) * 1994-10-20 1994-12-07 Glaxo Group Ltd Medicaments
AU2022497A (en) * 1996-03-13 1997-10-01 Novo Nordisk A/S A method of treating disorders related to cytokines in mammals
WO1997033591A1 (en) * 1996-03-13 1997-09-18 Novo Nordisk A/S A method of treating disorders related to cytokines in mammals
US6376472B1 (en) * 1996-07-08 2002-04-23 Aventis Pharmaceuticals, Inc. Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
IL139787A0 (en) 1998-06-02 2002-02-10 Osi Pharm Inc PYRROLO [2, 3d] PYRIMIDINE COMPOSITIONS AND THEIR USE
US6686366B1 (en) 1998-06-02 2004-02-03 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A3 receptor and uses thereof
US6878716B1 (en) 1998-06-02 2005-04-12 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A1 receptor and uses thereof
US6784165B1 (en) 1999-11-23 2004-08-31 Aderis Pharmaceuticals, Inc. Treatment of heart rhythm disturbances with N6-substituted-5′-(N-substituted) carboxamidoadenosines
US7160890B2 (en) 1999-12-02 2007-01-09 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A3 receptor and uses thereof
US6680322B2 (en) 1999-12-02 2004-01-20 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A1 receptors and uses thereof
US6664252B2 (en) 1999-12-02 2003-12-16 Osi Pharmaceuticals, Inc. 4-aminopyrrolo[2,3-d]pyrimidine compounds specific to adenosine A2a receptor and uses thereof
US6294522B1 (en) * 1999-12-03 2001-09-25 Cv Therapeutics, Inc. N6 heterocyclic 8-modified adenosine derivatives
GB9930083D0 (en) * 1999-12-20 2000-02-09 Glaxo Group Ltd Medicaments
GB9930077D0 (en) * 1999-12-20 2000-02-09 Glaxo Group Ltd Medicaments
US6680324B2 (en) 2000-12-01 2004-01-20 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A1 receptors and uses thereof
US6673802B2 (en) 2000-12-01 2004-01-06 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A3 receptor and uses thereof
GB0106867D0 (en) 2001-03-20 2001-05-09 Glaxo Group Ltd Process
EP1258247A1 (en) * 2001-05-14 2002-11-20 Aventis Pharma Deutschland GmbH Adenosine analogues for the treatment of insulin resistance syndrome and diabetes
DK1450811T3 (en) 2001-11-30 2010-02-15 Osi Pharm Inc Compounds specific for adenosine A1 and A3 receptors and uses thereof
CN1620294A (en) 2001-12-20 2005-05-25 Osi药物公司 Pyrimidine A2b selective antagonist compounds, their synthesis and use
DE60236458D1 (en) 2001-12-20 2010-07-01 Osi Pharm Inc PYRROLOPYRIMIDINE A2B SELECTIVE ANTAGONISTIC COMPOUNDS, THEIR SYNTHESIS AND USE
EP1633371A1 (en) * 2003-04-24 2006-03-15 Aderis Pharmaceuticals, Inc. Method of treating atrial fibrillation or atrial flutter
TWI494102B (en) * 2003-05-02 2015-08-01 Japan Tobacco Inc Combination comprising s-(2-(((1-(2-ethylbutyl)cyclohexyl)carbonyl)amino)phenyl)2-methylpropanethioate and an hmg coa reductase inhibitor
US20050118262A1 (en) * 2003-09-17 2005-06-02 Jack Aurora Controlled release formulation
CN101321460A (en) * 2005-11-30 2008-12-10 伊诺泰克制药公司 Purine derivatives and methods of use thereof
CN101712709A (en) * 2008-10-06 2010-05-26 中国医学科学院药物研究所 Tifluoroacetyl-3-hydroxyphenyl adenosine and use thereof in blood fat regulation
JP5955769B2 (en) * 2009-08-31 2016-07-20 ロンザ リミテッドＬｏｎｚａ Ｌｉｍｉｔｅｄ Method for producing (1S, 4R) -2-oxa-3-azabicyclo [2.2.1] hept-5-ene
TWI744723B (en) 2014-06-20 2021-11-01 美商基利科學股份有限公司 Synthesis of polycyclic-carbamoylpyridone compounds

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL130136C (en) * 1966-10-20
NL6717061A (en) * 1966-12-21 1968-06-24
DE2052596A1 (en) * 1970-10-27 1972-05-04 Boehringer Mannheim Gmbh, 6800 Mannheim Novel use of N (6) -substituted adenosine derivatives
NL7203984A (en) * 1971-04-10 1972-10-12
BE788958A (en) * 1971-09-18 1973-03-19 Schering Ag ADENOSINE DERIVATIVES AND THEIR PREPARATION PROCESS
DE2148838A1 (en) * 1971-09-30 1973-04-05 Boehringer Mannheim Gmbh NEW N (6) -DISUBSTITUTED ADENOSINE DERIVATIVES AND METHOD FOR MANUFACTURING THE SAME
DE2157036A1 (en) * 1971-11-17 1973-05-24 Boehringer Mannheim Gmbh NEW HETEROCYCLIC SUBSTITUTED NEBULARIN DERIVATIVES AND PROCESS FOR THEIR PRODUCTION
DE2244328A1 (en) * 1972-09-09 1974-03-21 Boehringer Mannheim Gmbh NEW N (6) -DISUBSTITUTED ADENOSINE DERIVATIVES AND METHOD FOR MANUFACTURING THE SAME
DE2338705A1 (en) * 1973-07-31 1975-02-13 Boehringer Mannheim Gmbh NEW N (6) -DISUBSTITUTED ADENOSINE DERIVATIVES AND METHOD FOR MANUFACTURING THE SAME
DE2338963A1 (en) * 1973-08-01 1975-02-13 Boehringer Mannheim Gmbh NEW N (6) -DISUBSTITUTED ADENOSINE DERIVATIVES AND METHOD FOR MANUFACTURING THE SAME
DE2426682A1 (en) * 1974-06-01 1975-12-11 Boehringer Mannheim Gmbh NEW N (6) -DISUBSTITUTED ADENOSINE DERIVATIVES AND METHOD FOR MANUFACTURING THE SAME
ZA857998B (en) * 1984-10-26 1986-05-28 Warner Lambert Co N6-substituted adenosines
AU579412B2 (en) * 1984-10-26 1988-11-24 Warner-Lambert Company N` - substituted adenosines

Also Published As

Publication number Publication date
EP0322242A3 (en) 1990-04-18
EP0322242B1 (en) 1998-04-01
SG44701A1 (en) 1997-12-19
EP0322242A2 (en) 1989-06-28
NZ227485A (en) 1991-06-25
FI90429B (en) 1993-10-29
FR2629715B1 (en) 1993-09-03
GB8729994D0 (en) 1988-02-03
DE3856154T2 (en) 1998-08-27
NO885719D0 (en) 1988-12-22
US5032583A (en) 1991-07-16
ATA315488A (en) 1994-02-15
ES2012927A6 (en) 1990-04-16
IL88765A (en) 1993-04-04
DK713488A (en) 1989-06-24
FR2629715A1 (en) 1989-10-13
HUT48903A (en) 1989-07-28
DK713488D0 (en) 1988-12-21
YU234188A (en) 1990-12-31
PL276697A1 (en) 1990-02-19
KR890009967A (en) 1989-08-05
MX14331A (en) 1993-12-01
AU8589491A (en) 1991-12-12
NL8803140A (en) 1989-07-17
IT8848714A0 (en) 1988-12-23
ZA889593B (en) 1989-09-27
IT1224840B (en) 1990-10-24
DE3843609A1 (en) 1989-07-06
AU612747B2 (en) 1991-07-18
FI90429C (en) 1994-02-10
CN1024198C (en) 1994-04-13
CN1035295A (en) 1989-09-06
GB2212498B (en) 1991-07-24
GR1000307B (en) 1992-05-12
NO885719L (en) 1989-06-26
PT89328A (en) 1989-12-29
IE61302B1 (en) 1994-10-19
CH677495A5 (en) 1991-05-31
HU203364B (en) 1991-07-29
RU2060996C1 (en) 1996-05-27
PL158800B1 (en) 1992-10-30
NO171506C (en) 1993-03-24
JP2736088B2 (en) 1998-04-02
SE8804609L (en) 1989-06-24
DK170894B1 (en) 1996-03-04
JPH01203400A (en) 1989-08-16
IE883845L (en) 1989-06-23
CZ403991A3 (en) 1993-04-14
PH25932A (en) 1991-12-19
SE8804609D0 (en) 1988-12-21
IL88765A0 (en) 1989-07-31
LU87414A1 (en) 1989-07-07
HK1009650A1 (en) 1999-06-04
NO171506B (en) 1992-12-14
GB8829983D0 (en) 1989-02-15
RU1826971C (en) 1993-07-07
BE1002167A5 (en) 1990-08-28
DE3856154D1 (en) 1998-05-07
GB2212498A (en) 1989-07-26
CA1320195C (en) 1993-07-13
AU2740188A (en) 1989-06-29
PT89328B (en) 1993-08-31

Similar Documents

Publication Publication Date Title
FI885943A (en) A process for the preparation of new therapeutically useful adenosine derivatives and intermediates
FI905941A0 (en) Process for the preparation of therapeutically useful heterocyclic 2-acylaminothiazole derivatives
FI892682A0 (en) Analog method for the preparation of therapeutically useful 1-deoxynojirimycin derivatives
FI881223A0 (en) Process for the preparation of therapeutically active substituted 9-aminotetrahydroacrines and related compounds
FI874459A (en) A process for the preparation of new therapeutically useful piperidine derivatives
FI850654L (en) A process for the preparation of therapeutically useful pleuromutilin derivatives
FI895417A0 (en) Process for the preparation of new therapeutically useful 2'-halomethylidene nucleosides
PT87191A (en) PROCESS FOR THE PREPARATION OF NUCLEOSIDES
FI891339A (en) A process for the preparation of new therapeutically useful aristeromycin / adenosine derivatives
FI92696C (en) A process for the preparation of therapeutically useful thiazolidinedione derivatives
FI883889A0 (en) A process for the preparation of new therapeutically useful aristeromycin / adenosine derivatives
FI883672A (en) A process for the preparation of therapeutically useful aminoalkoxyphenyl derivatives
FI883997A0 (en) Process for the preparation of therapeutically useful substituted 2-phenyl-4-quinolinecarboxylic acids
FI102678B1 (en) A process for the preparation of therapeutically useful ethers of 1-benzyl-3-hydroxymethylindazole and an intermediate compound
FI895393A0 (en) Process for the preparation of therapeutically useful alkyl-substituted 2-alkylamine benzopyran-6-ols
FI93444B (en) Process for the preparation of therapeutically active dihydropyridine derivatives
FI892948A0 (en) A process for the preparation of therapeutically useful chromium derivatives
FI95701C (en) A process for the preparation of therapeutically useful chromium derivatives
FI893003A (en) A process for the preparation of new therapeutically useful neplanosin derivatives
FI914418A0 (en) Process for the preparation of 9-substituted guanine derivatives and intermediates for use in the process
FI92064C (en) A process for the preparation of therapeutically useful N-benzopyranyl lactams
FI92825C (en) A process for the preparation of therapeutically useful chromium derivatives
FI884473A (en) A process for the preparation of therapeutically useful phenoxyalkylpyrocatechol derivatives
FI892420A (en) A process for the preparation of therapeutically useful 2-aminoethanol derivatives
FI863471A0 (en) A process for the preparation of therapeutically useful 3-desmethylmevalonic acid derivatives

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed

Owner name: GLAXO GROUP LIMITED